SUTRO BIOPHARMA, INC. (STRO) Net margin 2016–2025
SUTRO BIOPHARMA, INC. (STRO) net profit margin by fiscal year — reported net income divided by reported revenue.
-186.4%FY2025 · since FY2016: 2.8% → -186.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -186.4% | +179.5 pp |
| FY2024 | -365.9% | -296.3 pp |
| FY2023 | -69.6% | +106.3 pp |
| FY2022 | -175.9% | -5.3 pp |
| FY2021 | -170.6% | -95.4 pp |
| FY2020 | -75.2% | +203.7 pp |
| FY2019 | -278.9% | -187.0 pp |
| FY2018 | -91.9% | -53.9 pp |
| FY2017 | -38.1% | -40.9 pp |
| FY2016 | 2.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice